Insider · CIK 0001705562
Philip Hodges
Files at ALT (Altimmune, Inc.). First filing -, latest -.
In brief
Philip Hodges files SEC Form 4 as director at ALT (Altimmune, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Philip Hodges has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +48,800 | $0.00 | $0 | 48,800 | May 1, 2026 |
| Sep 25, 2025 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +48,800 | $0.00 | $0 | 48,800 | Sep 29, 2025 |
Questions about Philip Hodges
Answered from the filings on this page, as of the latest one.
Is Philip Hodges buying or selling?
Philip Hodges has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Philip Hodges's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Philip Hodges has 0.
Where does Philip Hodges file Form 4?
Philip Hodges has filed Form 4 at ALT (Altimmune, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.